Patent Information Users Group, Inc.
The International Society for Patent Information Professionals
Wednesday, February 9, 2011
611 Gateway Blvd. Building 83
South San Francisco, CA 94080
Branching out to the West Coast for its fifth annual meeting, the PIUG Biotechnology Meeting focuses on methodologies and resources for patent information professionals who specialize in biotechnology search and analysis. This year’s theme is New Biologics: Proteins & Beyond.
Biotechnology in 2011 has come a long way since its origin. The distinction between biologics and small-molecule compounds is beginning to blur as we now see hybrid molecules and completely new modalities: antibody drug conjugates, peptidomimetics, antibody fragments, RNAi, etc. When we consider freedom-to-operate on biotech targets we now need to consider patent expiry, supplementary protection certificates, and other related patents.
Meeting capacity: 100 registrants (pre-registration is strongly suggested)
Registration ends February 9, 2011.
Registration fees (USD):
members (through Jan. 25, 2011)
all registrants, Jan. 26 through Feb. 8, 2011
|100.00||on-site registration (Feb. 9)|
|30.00||Reduced rate for students, retirees, and unemployed attendees|
Meeting registrants are invited to attend a tour of the Genentech Cell Culture and Purification Pilot Plants. The tour will be held February 8, 2011, 4:00-4:30pm at Building 6.
- If you are staying at the conference hotel (Courtyard by Marriot Oyster Point Waterfront), a shuttle will depart at 3:30pm for the tour. The shuttle will return you to the hotel after the tour.
- If you are not staying at the hotel you will need to find transportation to the tour (map of Genentech). Upon your arrival, please sign in with the B5 receptionist (Main Campus).
Please respond to Ruben Diaz (650.225.6122) by Friday, February 4, if you wish to attend. Tour attendance is limited to the first fifty (50) who respond.
|Monica Weiss-Nolen, Chair||Sanofi Pasteur|
|Alice Goshorn||Bristol-Myers Squibb|
|Qin Meng||Amgen Inc|
|Elyse Turner||Merck & Co. Inc|
|Evaluation:||Sian Griffiths||Millennium Pharmaceuticals, Inc|
|Registration:||Ken Koubek||Koubek Information Consulting Svcs|
|Moninder Tank||Sagacious Research|
|Kim Spytek||Novartis Institutes for Biomedical Research|
|Fundraising:||Christine Geluk||Eisai Corporation of North America|
|Helen Oen||Eisai Corporation of North America|
|Planning/Travel:||Doreen Alberts, Chair||Theravance Inc.|
|Web Pages:||Rick Williams||Vertex Pharmaceuticals, Inc|
|Tom Wolff||Wolff Information Consulting LLC|
|Meeting Book:||Alison Taylor||Abbott Laboratories|
|Dianne Webb||BizInt Solutions, Inc.|